PRONAI THERAPEUTICS INC has a total of 49 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are NAT CENTER NEUROLOGY & PSYCHIATRY, MIRNA THERAPEUTICS INC and NAT CT NEUROLOGY & PSYCHIATRY.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 9 | |
#3 | EPO (European Patent Office) | 8 | |
#4 | Canada | 5 | |
#5 | Australia | 3 | |
#6 | China | 3 | |
#7 | Hong Kong | 3 | |
#8 | Brazil | 2 | |
#9 | Israel | 2 | |
#10 | Japan | 2 | |
#11 | Republic of Korea | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Measuring microorganism processes | |
#5 | Analysing materials | |
#6 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Sooch Mina Patel | 29 |
#2 | Goodwin Neal | 16 |
#3 | Rodrigueza Wendi Veloso | 15 |
#4 | Messmann Richard Adam | 14 |
#5 | Sheikhnehjad Gholamreza | 13 |
#6 | Olson David | 13 |
#7 | Goodwin Neal Clifford | 12 |
#8 | Gaylor Shari Kay | 12 |
#9 | Woolliscroft Michael James | 12 |
#10 | Rodrigueza Wendi | 8 |
Publication | Filing date | Title |
---|---|---|
AU2015213349A1 | Methods and compositions for the inhibition of gene expression | |
US2015164936A1 | Methods and compositions for the inhibition of gene expression | |
WO2014144942A2 | Dnai for the modulation of genes | |
CN104884637A | Methods of using biomarkers for the treatment of cancer by modulation of BCL2 expression | |
WO2014071379A1 | Dosing and administration of oligonucleotide cancer therapies | |
AU2012202547A1 | Methods and compositions for the inhibition of gene expression | |
WO2009051712A1 | Dnai amphoteric liposome formulation | |
WO2008103431A2 | Dnai - liposomes | |
EP1957044A2 | Amphoteric liposome formulation | |
WO2007065017A2 | Oligonucleotide cationic liposomal delivery system | |
EP1971371A2 | Cancer therapies and pharmaceutical compositions used therein | |
WO2007064853A2 | Locked nucleic acid oligonucleotides | |
US2007213285A1 | Methods and compositions for cancer therapy | |
US2005287667A1 | Methods and compositions for the inhibition of gene expression |